™,
`mY
`
`—
`
`WIPO
`WORLD
`INTELLECTUAL PROPERTY
`ORGANIZATION
`
`DOCUMENT MADE AVAILABLE UNDER THE
`PATENT COOPERATION TREATY (PCT)
`International application number:
`PCT/CA2019/050981
`
`International filing date:
`
`16 July 2019 (16.07.2019)
`
`Documenttype:
`
`Documentdetails:
`
`Certified copy of priority document
`
`Country/Office:
`Number:
`Filing date:
`
`US
`62/698,799
`16 July 2018 (16.07.2018)
`
`Date of receipt at the International Bureau:
`
`25 July 2019 (25.07.2019)
`
`Remark: Priority document submitted or transmitted to the International Bureau in compliance with Rule
`17.1(a),(b) or (b-bis)
`
`34, chemin des Colombettes
`1211 Geneva 20, Switzerland
`
`www.wipo.int
`
`Petitioner's Exhibit 1003
`Page | of 65
`
`Petitioner's Exhibit 1003
`Page 1 of 65
`
`

`

`Diaital A
`igital Access
`(DAS)
`
`Servi
`vervice
`
`WIPO
`WORLD
`INTELLECTUAL PROPERTY
`ORGANIZATION
`
`CERTIFICATE OF AVAILABILITY OF A CERTIFIED PATENT DOCUMENT INA
`DIGITAL LIBRARY
`
`The International Bureau certifies that a copy of the patent application indicated
`below has been available to the WIPO Digital Access Service since the date of
`availability indicated, and that the patent application has been available to the
`indicated Office(s) as of the date specified following the relevant Office code:
`
`Documentdetails:
`
`Country/Office: US
`
`Filing date: 16 Jul 2018 (16.07.2018)
`
`Application number: 62698799
`
`Date of availability of document:
`
`03 Aug 2018 (03.08.2018)
`
`The following Offices can retrieve this document by using the access code:
`JP, US, GE, SE, NZ, KR, IL, EA, IN, BR, GB, AU, CA, EP, ES, NL, IB,
`EE, CN, MA, FI, DK, CL
`
`Date of issue of this certificate:
`
`25 Jul 2019 (25.07.2019)
`
`34, chemin des Colombettes
`1211 Geneva 20, Switzerland
`
`Petitioner's Exhibit 1003
`Page 2 of 65
`
`Petitioner's Exhibit 1003
`Page 2 of 65
`
`

`

`
`
`
`
`SS
`
`<
`
`se
`
`“UNTYED STATES DEPARTAMENTOCOMMERCE
`
`United States Patentand Trademark Uffice
`
`July 25, 2019
`
`
`
`
`
`
`
`
`
`
`NG
`
`CAS
`
`
`
`
`“
`
`
`
`
`. AS
`SENS
`as
`ESS
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Ss
`Soe
`x ox
`:oe NS
`PREVSL
`NEE
`
`LERSTN
`CV PN SOREOS
`
`
`
`
`SENs
`~
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` APPLICATION NUMBER: 62/698,799
`
`THIS IS TO CERTIFY THAT ANNEXED HERETOIS A TRUE COPY FROM
`THE RECORDSOF THE UNITED STATES PATENT AND TRADEMARK
`OFFICE OF THOSE PAPERS OF THE BELOW IDENTIFIED PATENT
`APPLICATION THAT MET THE REQUIREMENTSTO BE GRANTED A
`FILING DATE UNDER35 USC 111.
`
`FILING DATE: July 16, 2018
`
`
`
`
`
`
` RGRASRROpotatodnteers
`
`
`
`
`
`Bhan (tne
`
`
`THE COUNTRY CODE AND NUMBEROF YOUR PRIORITY
`APPLICATION, TO BE USED FOR FILING ABROAD UNDER THE PARIS
`CONVENTION,IS US62/698,799
`
`
`
`Certified by
`
`fe
`
`é
`
`Lander Seerefary of Commerce
`fer bitehectual Fraperty
`and Dirveter of the United States
`Patent and Yrademark Office
`
`
`
`
`
`
`Petitioner's Exhibit 1003
`Page 3 of 65
`
`Petitioner's Exhibit 1003
`Page 3 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`—
`
`document may be printed and included in a paperfiled application.
`
`Title of Invention|Apparatus for visualization of tissue
`
`The application data sheetis part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`
`Secrecy Order 37 CFR 5.2:
`
`Oo Portions orall of the application associated with this Application Data Sheet mayfall under a Secrecy Order pursuant to
`
`37 CFR 5.2 (Paperfilers only. Applications that fall under Secrecy Order may notbefiled electronically.)
`
`Inventor Information:
`
`{1
`
`Inventor
`Legal Name
`
`[Pref]GivenName=MiddleName===FamllyName‘|‘Sufi
`Le}uennadtBako
`Residence Information (Select One) Active US Military Service US Residency e@ Non US Residency
`
`
`
`
`Remove
`
`egal Name
`
`Mailing Addressof Inventor:
`Address 1|para Trondheim Cr
`Address 2
`
`
`ity—s|| ississauga State/Province | en
`
`Postal Code|L5N1P4
`
`Inventor
`Legal Name
`[Prefiy|GivenName=|MiddleName«|FamilyName|Sufi
`{EfKennethako
`Residence Information (Select One)
`US Residency
`(@) Non US Residency
`Active US Military Service
`
`||c
`
`
`
`Mailing Addressof Inventor:
`Address 1|F 15-80 St Patrick St,
`Address 2 PP
`
`a L
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 4 of 65
`
`Petitioner's Exhibit 1003
`Page 4 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`—
`
`Title of Invention|Apparatus for visualization of tissue
`
`Residence Information (Select One)
`
`US Residency
`
`(@) Non US Residency
`
`Active US Military Service
`
`Middle Name
`
`a Name
`
`[aaivesst(eter
`Address?[|]
`
`generated within this form by selecting the Add button.
`
`
`
`|[
`
`PostalCodePiweca<icountyACS
`All
`Inventors Must Be Listed - Additional
`Inventor Information blocks may be
`
`CorrespondenceInformation:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`bx] An Addressis being provided for the correspondenceInformation of this application.
`[Namnet[paniedName?
`aawesst(frome —SSSCSCSCSCSCSCSCSCSC“‘“‘“‘;<CS;CSCS*d
`[Address?=Buleteon——SSSSOSCSCSCSCCCCSCSCSC
`reiy(fone———C*dziSteProvinceTPN
`County [PA*diPtalcodeeT
`Phone Number PoFaxNumberP|
`
`Email Address
`gsayko@yahoo.com
`
`Application Information:
`
`Title of the Invention
`Apparatusfor visualization of tissue
`Attorney Docket Numberfo Small Entity Status Claimed
`
`[><]
`
`Subject Matter a
`Total Number of Drawing Sheets (if any) fo Suggested Figure for Publication(if any) fo
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 5 of 65
`
`Petitioner's Exhibit 1003
`Page 5 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`—
`
` Application Data Sheet 37 CFR 1.76
`
`
`
`Title of Invention|Apparatus for visualization of tissue
`
`Filing By Reference:
`
`Only complete this section whenfiling an application by reference under 35 U.S.C. 111(c) and 37 CFR 1.57{a). Do not complete this sectionif
`application papers including a specification and any drawings are beingfiled. Any domestic benefit or foreign priority information must be
`provided in the appropriate section(s) below (i.e., "Domestic Benefit/National Stage Information” and “Foreign Priority Information”).
`
`For the purposesof a filing date under 37 CFR 1.53(b), the description and any drawings of the present application are replaced by this
`reference to the previously filed application, subject to conditions and requirements of 37 CFR 1.57(a).
`
`i
`
`Application numberof the previously
`filed application
`
`Filing date (YYYY-MM-DD}
`
`Intellectual Property Authority or Country
`
`Publication Information:
`
`
`[_] Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`
`Request Not to Publish. | hereby requestthat the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months afterfiling.
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a powerof attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Numberwill be used for the Representative Information during processing.
`
`©) Limited Recognition (37 CFR 11.9)
`
`Please Select One:
`
`e Customer Number
`
`US Patent Practitioner
`
`Domestic Benefit/National Stage Information:
`
`
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119¢e), 120, 121, 365(c), or 386(c} or indicate
`National Stage entry from a PCT application. Providing benefit claim information in the Application Data Sheet constitutes
`the specific reference required by 35 U.S.C. 119{e) or 120, and 37 CFR 1.78.
`Whenreferring to the current application, please leave the “Application Number”field blank.
`
`
`
`
`
`
`Prior Application Status Po
`
`Filing or 371(c) Date
`
`
`
`Prior Application Number
`(YYYY-MM-DD)
`
`
`
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
` by selecting the Add button.
`
`Application Number
`
`Continuity Type
`
`Remove
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 6 of 65
`
`Petitioner's Exhibit 1003
`Page 6 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`—
`
`
`
`Title of Invention|Apparatus for visualization of tissue
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55. Whenpriority is claimed to a foreign application
`that is eligible for retrieval under the priority document exchange program (PDX)! the information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55(1)(1) and (2). Under the PDX program, applicant bears the ultimate
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`property office, or a certified copy of the foreign priority applicationis filed, within the time period specified in 37 CFR 1.55{g)(1).
`
`Remove
`
`Access Code (if applicable)
`
`Application Number
`
`I
`
`Filing Date (YYYY-MM-DD)
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add
`Add button.
`
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effectivefiling date on or after March
`[] 16, 2013.
`NOTE: By providing this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`
`16, 2013, will be examined underthefirst inventorto file provisions of the AIA.
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 7 of 65
`
`Petitioner's Exhibit 1003
`Page 7 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`— Title of Invention|Apparatus for visualization of tissue
`
`Authorization or Opt-Out of Authorization to Permit Access:
`
`
`Whenthis Application Data Sheet is properly signed and filed with the application, applicant has provided written
`authority to permit a participating foreign intellectual property (IP) office access to the instant application-as-filed (see
`paragraph A in subsection 1 below) and the European Patent Office (EPO) access to any search results from the instant
`application (see paragraphBin subsection 1 below).
`
`Should applicant choose not to provide an authorization identified in subsection 1 below, applicant must opt-out of the
`authorization by checking the corresponding box A or B or both in subsection 2 below.
`
`
`
`NOTE: This section of the Application Data Sheet is ONLY reviewed and processed with the INITIALfiling of an
`application. After the initial filing of an application, an Application Data Sheet cannot be used to provide or rescind
`authorization for access by a foreign IP office(s). Instead, Form PTO/SB/39 or PTO/SB/69 must be used as appropriate.
`
`1. Authorization to Permit Access by a Foreign Intellectual Property Office(s)
`
`
`A. Priority Document Exchange (PDX)- Unless box A in subsection 2 (opt-out of authorization) is checked, the
`undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO), the Japan Patent Office
`JPO), the Korean Intellectual Property Office (KIPO), the State Intellectual Property Office of the People’s Republic of
`China (SIPO), the World Intellectual Property Organization (WIPO), and any other foreign intellectual property office
`participating with the USPTOin a bilateral or multilateral priority document exchange agreementin which a foreign
`application claiming priority to the instant patent application is filed, access to: (1) the instant patent application-as-filed
`andits related bibliographic data, (2) any foreign or domestic application to which priority or benefit is claimed by the
`instant application andits related bibliographic data, and (3) the date offiling of this Authorization. See 37 CFR 1.14(h)
`(1).
`
`
`B. Search Results from U.S. Application to EPO - Unless box B in subsection 2 (opt-out of authorization) is checked,
`the undersigned hereby grants the USPTO authority to provide the EPO accessto the bibliographic data and search
`results from the instant patent application when a European patent application claiming priority to the instant patent
`application is filed. See 37 CFR 1.14(h}(2).
`
`the instant application.
`
`The applicant is reminded that the EPO’s Rule 141(1) EPC (European Patent Convention} requires applicants to submit a
`copy of search results from the instant application without delay in a European patent application that claims priority to
`
`2. Opt-Out of Authorizations to Permit Access by a Foreign Intellectual Property Office(s)
`
`[|
`
`A. Applicant DOES NOT authorize the USPTOto permit a participating foreign IP office access to the instant
`application-as-filed.
`If this box is checked, the USPTOwill not be providing a participating foreign IP office with
`any documents and information identified in subsection 1A above.
`
`[|
`
`B. Applicant DOES NOTauthorize the USPTOto transmit to the EPO any search results from the instant patent
`application. If this box is checked, the USPTOwill not be providing the EPO with search results from the instant
`application.
`NOTE: Once the application has published or is otherwise publicly available, the USPTO may provide accessto the
`application in accordance with 37 CFR 1.14.
`
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 8 of 65
`
`Petitioner's Exhibit 1003
`Page 8 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`— Title of Invention|Apparatus for visualization of tissue
`
`Applicant Information:
`
`
`Providing assignment information in this section does not substitute for compliance with any requirementof part 3 of Title 37 of CFR
`
`to have an assignment recorded by the Office.
`
`#1
`Applicant
`lf the applicantis the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and addressof the legal representative whois the applicant under 37 CFR
`1.43; or the name and addressof the assignee, person to whom the inventoris under an obligation to assign the invention, or person
`who otherwise showssufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise showssufficient
`proprietary interest) together with one or morejoint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`Legal Representative under 35 U.S.C. 117
`
`@
`
`Joint Inventor
`
`Person to whom theinventoris obligated to assign.
`
`Person who showssufficient proprietary interest
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventoris:
`
`
`
`
`
`
`Nameof the Deceased or Legally Incapacitated Inventor:Po
`
`If the Applicant is an Organization check here.
`[]
`
`———§— MiddleName
`Prefix
`Mailing Address olbe ForApplicant:
`Address 1
`| paz4 Trondheim Cr
`
`FamilyName
`
`Add
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 9 of 65
`
`Petitioner's Exhibit 1003
`Page 9 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`—
`Application Number
`
`Title of Invention|Apparatus for visualization of tissue
`
`Applicant b
`
`lf the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and addressof the legal representative who is the applicant under 37 CFR
`1.43; or the name and addressof the assignee, person to whom the inventoris under an obligation to assign the invention, or person
`who otherwise showssufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 {assignee, person to whom the inventor is obligated to assign, or person who otherwise showssufficient
`proprietary interest) together with one or morejoint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`Assignee
`
`Legal Representative under 35 U.S.C. 117
`
`@ Joint Inventor
`
`Person to whom theinventoris obligated to assign.
`
`Person who showssufficient proprietary interest
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventoris:
`
`Name of the Deceased or Legally Incapacitated Inventor:
`
`If the Applicant is an Organization check here.
`
`Family Name
`
`Suffix
`
`[|
` |Preix«|GivenName|Middle Name
`
`Mailing Address Information For Applicant:
`raaaresst|Prsevstraverst
`
`ar
`
`oyfoeidStonePN
`[County[PAidee
`Fax Number
`Phone Number
`
`Email Address
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Add
`
`2
`Applicant
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and addressof the legal representative whois the applicant under 37 CFR
`1.43; or the name and addressof the assignee, person to whom the inventoris under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 {assignee, person to whom theinventor is obligated to assign, or person who otherwise showssufficient
`proprietary interest) together with one or morejoint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`Assignee
`
`Legal Representative under 35 U.S.C. 117
`
`@)
`
`Joint Inventor
`
`Person to whomtheinventoris obligated to assign.
`
`Person who showssufficient proprietary interest
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 10 of 65
`
`Petitioner's Exhibit 1003
`Page 10 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`—
`
`Title of Invention|Apparatus for visualization of tissue
`
`Nameof the Deceased or Legally Incapacitated Iventor:|sis
`If the Applicant is an Organization check here.
`[|
`
`Pets‘|Gente|leave|FaryNone.[Sule
`eeee
`
`
`|MailingAddressInformationForApplicant:
`Mailing Address Information For Applicant:
`pAddresst(PGS
`
`ar
`
`eiy|PoweidsSirens
`eeetce o
`
`
`
`
`Phone Number
`
`Email Address
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Assignee Information including Non-Applicant Assignee Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirementof part 3 ofTitle
`37 of CFR to have an assignment recorded by the Office.
`
`Inc
`
`, C
`
`omplete this section if assignee information, including non-applicant assignee information, is desired to be included on the patent
`application publication. An assignee-applicant identified in the "Applicant Information” section will appear on the patent application
`publication as an applicant. For an assignee-applicant, complete this section only if identification as an assigneeis also desired on the
`patent application publication.
`
`Assignee
`
`If the Assignee or Non-Applicant Assignee is an Organization check here.
`
`Organization Name PinOSS
`
`Remove
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 11 of 65
`
`Petitioner's Exhibit 1003
`Page 11 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`—
`
`Title of Invention|Apparatus for visualization of tissue
`
`Mailing Address Information For Assignee including Non-Applicant Assignee:
`
`YongeSt, Suite 1801
`Address 1
`iCn
`Address 2
`etyfonC*dStaterovince[PN
`eo[enepe
`
`Phone Number
`
`
`
`
`Additional Assignee or Non-Applicant Assignee Data may be generated within this form by
`selecting the Add button.
`
`Signature:
`
`NOTE: This Application Data Sheet must be signed in accordance with 37 CFR 1.33(b). However,if this Application
`
`Data Sheet is submitted with the INITIALfiling of the application and either box A or B is not checked in
`subsection 2 of the “Authorization or Opt-Out of Authorization to Permit Access”section, then this form must
`also be signed in accordance with 37 CFR 1.14(c).
`This Application Data Sheet must be signed by a patent practitioner if one or more of the applicants is a juristic
`entity (€.g., corporation or association). If the applicant is two or more joint inventors, this form must be signed by a
`patent practitioner, all joint inventors who are the applicant, or one or morejoint inventor-applicants who have been given
`powerof attorney (e.g., see USPTO Form PTO/AIA/81) on behalf ofall joint inventor-applicants.
`See 37 CFR 1.4(d} for the manner of making signatures and certifications.
`
`
`Date (YYYY-MM-DD};018-07-15
`guennadisaiko/
`
`
`
`
`First Name Last Name|Saikouennadi Registration Number
`
`
`Add
`Additional Signature may be generated within this form by selecting the Add button.
`
`
`
`Remove
`Signature:
`NOTE: This Application Data Sheet must be signed in accordance with 37 CFR 1.33(b). However,if this Application
`Data Sheet is submitted with the INITIALfiling of the application and either box A or B is not checkedin
`subsection 2 of the “Authorization or Opt-Out of Authorization to Permit Access”section, then this form must
`also be signed in accordance with 37 CFR 1.14(c).
`This Application Data Sheet must be signed by a patent practitioner if one or more of the applicants is a juristic
`entity (¢.g., corporation or association). If the applicant is two or more joint inventors, this form must be signed by a
`patent practitioner, all joint inventors who are the applicant, or one or morejoint inventor-applicants who have been given
`power of attorney (e.g., see USPTO Form PTO/AIA/81) on behalf ofall joint inventor-applicants.
`See 37 CFR 1.4(d} for the manner of making signatures andcertifications.
`
`
`
`kennethmacko/
`
`EFS Web 2.2.13
`
`Fisinane|FeitastNae[foo—————*d Region Naber [[
`
`Date (YYYY-MM-DD)oe07-15
`
`Petitioner's Exhibit 1003
`Page 12 of 65
`
`Petitioner's Exhibit 1003
`Page 12 of 65
`
`

`

`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`— Title of Invention|Apparatus for visualization of tissue
`
`Add
`Additional Signature may be generated within this form by selecting the Add button.
`
`
`Signature:
`NOTE: This Application Data Sheet must be signed in accordance with 37 CFR 1.33(b). However,if this Application
`Data Sheet is submitted with the INITIALfiling of the application and either box A or B is not checkedin
`subsection 2 of the “Authorization or Opt-Out of Authorization to Permit Access” section, then this form must
`also be signed in accordance with 37 CFR 1.14(c).
`This Application Data Sheet must be signed by a patent practitioner if one or more of the applicants is a juristic
`entity (e.g., corporation or association). If the applicant is two or more joint inventors, this form must be signed by a
`patent practitioner, all joint inventors who are the applicant, or one or more joint inventor-applicants who have been given
`powerof attorney (e.g., see USPTO Form PTO/AIA/81) on behalf ofall joint inventor-applicants.
`See 37 CFR 1.4(d} for the manner of making signatures and certifications.
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`Date (YYYY-MM-DD)|
`
`2018-07-15
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandna, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 13 of 65
`
`Petitioner's Exhibit 1003
`Page 13 of 65
`
`

`

`Privacy Act Statement
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552) and the Privacy
`Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Departmentof Justice to determine whether the Freedom of
`Information Act requires disclosure of these records.
`
`Arecord from this system of records may be disclosed,as a routine use,in the course of presenting evidence to a court, magistrate, or administrative
`tribunal, including disclosures te opposing counsel in the course of settlement negotiations.
`
`Arecordin this system of records may be disclosed, as a routine use, to a Memberof Congress submitting a request involving an individual, to whom
`the record pertains, when the individual has requested assistance from the Memberwith respect to the subject matter of the record.
`
`Arecordin this system of records may be disclosed,as a routine use, to a contractor of the Agency having need for the information in order to perform
`acontract. Recipients of information shall be required to comply with the requirementsof the Privacy Act of 1974, as amended, pursuantto 5 U.S.C.
`552a(m).
`
`Arecord related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed, as a routine use,
`to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent CooperationTreaty.
`
`Arecordin this system of records may be disclosed,as a routine use, to another federal agency for purposes of National Security review (35 U.S.C. 181)
`and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`Arecord from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee, during an
`inspection of records conducted by GSAas part of that agency's responsibility to recommend improvementsin records managementpractices and
`programs, underauthority of 44 U.S.C. 2904 and 2906. Such disclosure shall be madein accordance with the GSA regulations governing inspection of
`records for this purpose, and any otherrelevant(i.e., GSA or Commerce)directive. Such disclosure shall not be used to make determinations about
`individuals.
`
`Arecord from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuantto 35 U.S.C.
`122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subjectto the limitations of 37 CFR 1.14, as a routine use,
`to the public if the record wasfiled in an application which became abandonedorin which the proceedings were terminated and which applicationis
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`Arecord from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency,if the USPTO becomes
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to a patent
`application or patent. Accordingly, pursuant to the requirementsof the Act, please be advised that: (1) the general authority for the collection of this information
`is 35 U.S.C. 2(b)(2); (2) furnishing of the information sclicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and
`Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not furnish the requested information, the U.S.
`Patent and Trademark Office may not be able to process and/or examine your submission, which mayresult in termination of proceedings or abandonmentof
`the application or expiration of the patent.
`
`awareof a violation or potential violation of law or regulation.
`
`EFS Web 2.2.13
`
`Petitioner's Exhibit 1003
`Page 14 of 65
`
`Petitioner's Exhibit 1003
`Page 14 of 65
`
`

`

`TITLE: APPARATUS FOR VISUALIZATION OF TISSUE
`
`FIELD
`
`[0001]
`
`The improvements generally relate to thefield of medical devices.
`
`INTRODUCTION
`
`[0002]
`
`People suffer from chronic and compromised wounds with debilitating pain and
`
`reduced quality of life for those whose health is already compromised. Patients with this
`
`condition often present to a doctor at late stages of the disease, which leads to many
`
`amputations, which may be avoidable. Moreover, proper diagnostics requires specialized
`
`10
`
`vascular labs, which precludes these types of tests from being performed outside major
`
`hospitals and in an expedited fashion.
`
`[0003]
`
`The wound is considered chronic if it is not healed within four weeks. The tissue
`
`health and wound healing process can be compromised by various factors,
`
`including
`
`insufficient
`
`blood
`
`supply,
`
`edema,
`
`and the pres